Tag

Advertisement

Orexo

Business Q&A: The four Ps of market entry

July 4, 2022

Patent, pricing, production, and partnerships …

Nikolaj Sørensen

Orexo initiates new development project

December 3, 2021

Orexo has initiated a new …

Orexo announces positive trial results

November 16, 2021

Orexo has completed the trial …

Nikolaj Sørensen

First patient enrolled in Orexo’s modia trial

July 2, 2021

The company announces that the …

Orexo announces new US patent

January 5, 2021

Orexo has announced that the …

Nikolaj Sorensen Photo Jenny Ohman Nordic Life Science

Orexo enters license and supply agreement with Accord Healthcare

December 10, 2020

Orexo has entered into an …

Orexo receives paragraph IV Notice Letter in the US

August 12, 2020

Orexo has received a “paragraph …

Nikolaj Sorensen Photo Jenny Öhman

Orexo acquires US rights to commercialize vorvida

November 28, 2019

Orexo has acquired the exclusive …

Nikolaj_Sorensen_OrexoAB-554x350

Orexo receives USD 2.5 million milestone payment

June 2, 2017

Orexo announces that the OX-CLI …

orexo nikolaj sorensen

Orexo enters patent infringement litigation against Actavis

March 2, 2017

Orexo has filed a patent …

orexo nikolaj sorensen

Orexo completes bond buyback program

February 21, 2017

Orexo AB announces that it …

orexo nikolaj sorensen

Orexo appeal Zubsolv US district court decision

December 14, 2016

Orexo has appealed the decision …

orexo nikolaj sorensen

Favorable outcome for Orexo in patent infringement litigation

November 18, 2016

Orexo announces that the United …

orexo nikolaj sorensen

Orexo announce EU regulatory submission

October 3, 2016

Mundipharma and Orexo have announced …

orexo nikolaj sorensen

AZ acquires all rights to Orexo’s OX-CLI

March 21, 2016

AstraZeneca has decided to acquire …

Orexo’s ZUBSOLV approved

August 17, 2015

Orexo has announced that the …

1
2